IBDEI2U6 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45241,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,45242,0)
 ;;=Z91.5^^170^2258^1
 ;;^UTILITY(U,$J,358.3,45242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45242,1,3,0)
 ;;=3^Personal Hx of Suicide Attempt(s)
 ;;^UTILITY(U,$J,358.3,45242,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,45242,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,45243,0)
 ;;=R45.851^^170^2258^2
 ;;^UTILITY(U,$J,358.3,45243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45243,1,3,0)
 ;;=3^Suicidal Ideations
 ;;^UTILITY(U,$J,358.3,45243,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,45243,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,45244,0)
 ;;=T14.91XA^^170^2258^3
 ;;^UTILITY(U,$J,358.3,45244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45244,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,45244,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,45244,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,45245,0)
 ;;=T14.91XD^^170^2258^4
 ;;^UTILITY(U,$J,358.3,45245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45245,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,45245,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,45245,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,45246,0)
 ;;=T14.91XS^^170^2258^5
 ;;^UTILITY(U,$J,358.3,45246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45246,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,45246,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,45246,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,45247,0)
 ;;=Q3014^^171^2259^1^^^^1
 ;;^UTILITY(U,$J,358.3,45247,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,45247,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,45247,1,3,0)
 ;;=3^Telehealth Fac Fee-Pt Site
 ;;^UTILITY(U,$J,358.3,45248,0)
 ;;=B19.10^^172^2260^1
 ;;^UTILITY(U,$J,358.3,45248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45248,1,3,0)
 ;;=3^Hepatitis B w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,45248,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,45248,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,45249,0)
 ;;=B17.10^^172^2260^2
 ;;^UTILITY(U,$J,358.3,45249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45249,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
 ;;^UTILITY(U,$J,358.3,45249,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,45249,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,45250,0)
 ;;=B18.2^^172^2260^3
 ;;^UTILITY(U,$J,358.3,45250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45250,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,45250,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,45250,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,45251,0)
 ;;=B35.6^^172^2260^4
 ;;^UTILITY(U,$J,358.3,45251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45251,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,45251,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,45251,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,45252,0)
 ;;=B35.3^^172^2260^5
 ;;^UTILITY(U,$J,358.3,45252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45252,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,45252,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,45252,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,45253,0)
 ;;=B97.89^^172^2260^6
 ;;^UTILITY(U,$J,358.3,45253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45253,1,3,0)
 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,45253,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,45253,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,45254,0)
 ;;=B02.9^^172^2260^7
 ;;^UTILITY(U,$J,358.3,45254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45254,1,3,0)
 ;;=3^Zoster w/o Complications
